NuGen Medical Devices Inc. (TSXV: NGMD)

Market Cap	17.42M
Revenue (ttm)	762.79K
Net Income (ttm)	-8.31M
Shares Out	217.73M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Open	0.0800
Previous Close	0.0800
Day's Range	0.0800 - 0.0800
52-Week Range	0.0800 - 0.1550
Beta	2.55
Analysts	n/a
Price Target	n/a
Earnings Date	May 1, 2025

About NuGen Medical Devices

NuGen Medical Devices Inc., a specialty medical device company, develops and commercializes novel drug delivery technologies in Europe, Asia, North America, and internationally. The company offers needle-free injection devices and systems for the administration of subcutaneous medication for various fields, including diabetes, semaglutide, and growth and fertility hormone, as well as DNA and conventional/pediatric vaccines. It also provides InsuJet system that focuses on servicing the diabetic community; and V5, V6, V7, and V8 InsuJet injectors...

• Industry: Medical Devices
• Sector: Healthcare
• CEO: Karen Dunlap
• Country: Canada
• Stock Exchange: TSX Venture Exchange
• Ticker Symbol: NGMD

Financial Performance

In 2023, NuGen Medical Devices's revenue was 331,403, an increase of 117.52% compared to the previous year's 152,358. Losses were -9.36 million, 67.8% more than in 2022.